Search Results

You searched for : GileadScience  

Corona curfew starts in Bhopal to counter recent surge in Covid-19 cases

The curfew has been enforced from April 12, 9 PM till April 19, 6 am...
Apr 13

Strides receives USFDA approval for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets

The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug, Truvada Tablets, 200 mg/300 mg, of Gilead Sciences...
Jan 15

Gilead and Galapagos announce new commercialization and development agreement for Jyseleca

Gilead and Galapagos will continue to investigate the potential for filgotinib to support patients living with Inflammatory Bowel Disease...
Dec 16

WHO drops Gilead's Remdesivir from Prequalification list

With Remdesivir out from benchmark drugs for Covid Gilead could be severely impacted...
Nov 21

WHO Guideline Development Group advises against use of remdesivir for covid-19

Currently no evidence that it improves survival and other important measures ...
Nov 20

ProteoNic announces licensing of its 2G UNic Technology Platform to Gilead Sciences

...
Nov 07

WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivir

WHO-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but shunning Gilead's GILD....
Nov 06

Knight Therapeutics signs a new distribution agreement with Gilead Sciences

The agreement will enter into force as of 1st January 2021...
Oct 27

Remdesivir useless for severe Covid-19 patients : WHO

The search for effective drug continues for severely affected Covid patients...
Oct 17

Saptagir Laboratories enters into exclusive agreement with Jubilant Generics

Another Indian company joins Remdesivir production...
Sep 15

Gilead Sciences and Jounce Therapeutics announce exclusive license agreement for novel immunotherapy program

Gilead Sciences, Inc. collaborates with Jounce Therapeutics, Inc., focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers...
Sep 02

Gilead Sciences and Tango Therapeutics to expand strategic oncology collaboration

The collaboration excludes Tango’s lead programs, including one program that is expected to be in investigational new drug (IND) applicatation-enabling studies next year...
Aug 19

Gufic Lifesciences signs contract with Hetero Labs for Remdesivir lyophilised powder

Gufic Lifesciences has entered into a loan agreement with Hetero Labs Limited to manufacture and supply Remdesivir lyophilised powder ...
Aug 12

Everest Organics announces Remdesivir API manufacturing

Now Everest Organics will also manufacture Ramdesivir API...
Aug 12

Jubilant Life Sciences Limited announces launch of ‘JUBI-R’ (remdesivir) in India

Now Jubiliant launches Remdesivir at Rs 4700...
Aug 04

Hetero to deliver 60,000 vials of Covifor

Hetero gears up to deliver Remdesivir doses in India...
Jul 16

Mylan Secures Regulatory Approval for Remdesivir in India

Mylan will manufacture remdesivir in India and would sell at Rs4,800 which is 80% less than the price in developed countries...
Jul 10

US buys entire global stock of COVID-19 drug Remdesivir from Gilead

US books all Remdesivir produced by Gilead Sciences leaving nothing for others...
Jul 02

Hetero launches Remdesivir generic, COVIFOR in India for the treatment of COVID-19

Hetero launches Remdesivir generic named Covifor for Indian markets ...
Jun 23

FDA warns against the usage of Remdesivir along with malaria antiviral Hydroxychloroquine

Remdesivir and HCQ is a deadly combination, reports US FDA...
Jun 17

HM allows of HCQ in early stages of Coronavirus ; Remdesivir for moderate cases

Health Ministry drops Azithromycin, suggest HCQ and Remdesivir instead for COVID patients...
Jun 15

Gilead Sciences collaborates with Indian Companies for Remdesivir

Under the licensing agreements, the companies have a right to receive a technology transfer of the Gilead Sciences manufacturing process for remdesivir to enable them ...
May 13

Cipla Signed an Agreement with Gilead for COVID-19 Treatment

Cipla Enters Into a Licensing Agreement With Gilead to Expand Access to COVID-19 Treatment ...
May 13

Study Begins in US to Test Possible Coronavirus Treatment

In a draft research plan published last month, the World Health Organization said remdesivir was considered "the most promising candidate.”...
Feb 26

24 Matching result(s) found!

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026